abrdn Life Sciences Investors
HQL
73 hedge funds and large institutions have $147M invested in abrdn Life Sciences Investors in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 19 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 20
4% more capital invested
Capital invested by funds: $142M → $147M (+$5.63M)
1.25% less ownership
Funds ownership: 31.69% → 30.44% (-1.3%)
12% less funds holding
Funds holding: 83 → 73 (-10)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4.94M |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
+$2.92M |
| 3 |
PCM
Penserra Capital Management
Orinda,
California
|
+$1.36M |
| 4 |
LPL Financial
San Diego,
California
|
+$1.26M |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$7.89M |
| 2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$4.66M |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.99M |
| 4 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$1.83M |
| 5 |
TJHA
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
|
-$1.81M |
HQL Hedge Fund Activity: Q4 2025 in Review
73 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2025, worth a combined $147M — up 4% from $142M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of HQL and 11 opened new positions — a net loss of 8 holders — while 20 trimmed existing stakes and 28 added.
The largest buyer was Morgan Stanley, adding an estimated $4.94M. The largest seller was Saba Capital Management, cutting an estimated $7.89M.
- 73 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2025, down from 83 in Q3 2025.
- Funds reported $147M of abrdn Life Sciences Investors stock for Q4 2025, up 4% quarter-over-quarter.
- 11 funds opened new abrdn Life Sciences Investors positions in Q4 2025 and 19 closed out, a net change of -8 holders.
- The largest abrdn Life Sciences Investors buyer in Q4 2025 was Morgan Stanley, an estimated $4.94M added.
- The largest abrdn Life Sciences Investors seller in Q4 2025 was Saba Capital Management, an estimated $7.89M sold.
Based on aggregated 13F filings for Q4 2025.